A Panel of High Resolution Melting (HRM) Technology-Based Assays with Direct Sequencing Possibility for Effective Mutation Screening of EGFR and K-ras Genes

A Panel of High Resolution Melting (HRM) Technology-Based Assays with Direct Sequencing Possibility for Effective Mutation Screening of EGFR and K-ras Genes

Background: Increasing data from clinical trials support EGFR and K-ras mutation status as predictive markers of tumour response to EGFR-targeted therapies. Consequently, rapid and reliable mutation screening assays are demanded to guide rational use of EGFR-targeted therapies.

Bibliographic Details
Main Authors: Heideman, D. A. M., Thunnissen, F. B., Doeleman, M., Kramer, D., Verheul, H. M., Smit, E. F., Postmus, P. E., Meijer, C. J. L. M., Meijer, G.A., Snijders, P. J. F.
Format: Online
Language:English
Published: IOS Press 2009
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619054/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619054/

Similar Items